These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 36601048)
1. Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European Study. Windisch O; Benamran D; Dariane C; Favre MM; Djouhri M; Chevalier M; Guillaume B; Oderda M; Gatti M; Faletti R; Colinet V; Lefebvre Y; Bodard S; Diamand R; Fiard G Eur Urol Open Sci; 2023 Jan; 47():94-101. PubMed ID: 36601048 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the accuracy of multiparametric MRI for predicting prostate cancer pathology and tumour staging in the real world: an multicentre study. Kam J; Yuminaga Y; Krelle M; Gavin D; Koschel S; Aluwihare K; Sutherland T; Skinner S; Brennan J; Wong LM; Louie-Johnsun M BJU Int; 2019 Aug; 124(2):297-301. PubMed ID: 30714285 [TBL] [Abstract][Full Text] [Related]
3. Multiparametric Prostate MRI Accuracy of Prostate Imaging Reporting and Data System (v2.1) Scores 4 and 5: The Influence of Image Quality According to the Prostate Imaging Quality Score. Fuschi A; Suraci PP; Pastore AL; Al Salhi Y; Capodiferro P; Scalzo S; Rera OA; Valenzi FM; Di Dio M; Russo P; Al-Zubi MT; Al Demour S; Fathi Al-Rawashdah S; Mazzon G; Bellini D; Carbone I; Petrozza V; Bozzini G; Zucchi A; Pacini M; Tema G; De Nunzio C; Carbone A; Rengo M J Clin Med; 2024 Jun; 13(13):. PubMed ID: 38999353 [No Abstract] [Full Text] [Related]
4. Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy. Brembilla G; Lavalle S; Parry T; Cosenza M; Russo T; Mazzone E; Pellegrino F; Stabile A; Gandaglia G; Briganti A; Montorsi F; Esposito A; De Cobelli F Eur J Radiol; 2023 Jul; 164():110849. PubMed ID: 37141845 [TBL] [Abstract][Full Text] [Related]
5. Prostate Imaging Quality (PI-QUAL): A New Quality Control Scoring System for Multiparametric Magnetic Resonance Imaging of the Prostate from the PRECISION trial. Giganti F; Allen C; Emberton M; Moore CM; Kasivisvanathan V; Eur Urol Oncol; 2020 Oct; 3(5):615-619. PubMed ID: 32646850 [TBL] [Abstract][Full Text] [Related]
6. Predictive model using prostate MRI findings can predict candidates for nerve sparing radical prostatectomy among low-intermediate risk prostate cancer patients. Song G; Ruan M; Wang H; Lin Z; Wang X; Li X; Li P; Wang Y; Zhou B; Hu X; Liu H; Wang H; Guo Y Transl Androl Urol; 2020 Apr; 9(2):437-444. PubMed ID: 32420149 [TBL] [Abstract][Full Text] [Related]
7. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen. Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346 [TBL] [Abstract][Full Text] [Related]
8. Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification. Baboudjian M; Gondran-Tellier B; Touzani A; Martini A; Diamand R; Roche JB; Lacetera V; Beauval JB; Roumeguère T; Simone G; Benamran D; Fourcade A; Fiard G; van den Bergh RCN; Peltier A; Ploussard G Eur Urol Oncol; 2023 Aug; 6(4):406-413. PubMed ID: 36280445 [TBL] [Abstract][Full Text] [Related]
9. Quality assessment of prostate MRI by PI-QUAL score: Inter-reader agreement and impact on prostate cancer local staging at 3 Tesla. Coelho FMA; Amaral LTW; Mitsutake LKN; Mussi TC; Baroni RH Eur J Radiol; 2023 Aug; 165():110921. PubMed ID: 37336037 [TBL] [Abstract][Full Text] [Related]
10. Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer. Stabile A; Dell'Oglio P; De Cobelli F; Esposito A; Gandaglia G; Fossati N; Brembilla G; Cristel G; Cardone G; Deho' F; Losa A; Suardi N; Gaboardi F; Del Maschio A; Montorsi F; Briganti A Eur Urol Oncol; 2018 May; 1(1):29-36. PubMed ID: 31100225 [TBL] [Abstract][Full Text] [Related]
11. Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol. Luzzago S; Musi G; Catellani M; Russo A; Di Trapani E; Mistretta FA; Bianchi R; Cozzi G; Conti A; Pricolo P; Ferro M; Matei DV; Mirone V; Petralia G; de Cobelli O Urol Int; 2018; 101(1):56-64. PubMed ID: 29734177 [TBL] [Abstract][Full Text] [Related]
12. Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial. Giganti F; Dinneen E; Kasivisvanathan V; Haider A; Freeman A; Kirkham A; Punwani S; Emberton M; Shaw G; Moore CM; Allen C Eur Radiol; 2022 Feb; 32(2):879-889. PubMed ID: 34327583 [TBL] [Abstract][Full Text] [Related]
13. Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions. Sorce G; Stabile A; Lucianò R; Motterle G; Scuderi S; Barletta F; Pellegrino F; Cucchiara V; Gandaglia G; Fossati N; De Cobelli F; Montorsi F; Jeffrey Karnes R; Guccini I; Briganti A BJU Int; 2022 Feb; 129(2):201-207. PubMed ID: 34038039 [TBL] [Abstract][Full Text] [Related]
14. Impact of PI-QUAL on PI-RADS and cancer yield in an MRI-TRUS fusion biopsy population. Pötsch N; Rainer E; Clauser P; Vatteroni G; Hübner N; Korn S; Shariat SF; Helbich TH; Baltzer PAT Eur J Radiol; 2022 Sep; 154():110431. PubMed ID: 35803101 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1. Tamada T; Kido A; Yamamoto A; Takeuchi M; Miyaji Y; Moriya T; Sone T J Magn Reson Imaging; 2021 Jan; 53(1):283-291. PubMed ID: 32614123 [TBL] [Abstract][Full Text] [Related]
16. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748 [TBL] [Abstract][Full Text] [Related]
17. Preoperative MRI PI-RADS scores are associated with prostate cancer upstaging on surgical pathology. Pockros B; Stensland KD; Parries M; Frankenberger E; Canes D; Moinzadeh A Prostate; 2022 Feb; 82(3):352-358. PubMed ID: 34878175 [TBL] [Abstract][Full Text] [Related]
18. Quantitative ultrasound shear wave elastography (USWE)-measured tissue stiffness correlates with PIRADS scoring of MRI and Gleason score on whole-mount histopathology of prostate cancer: implications for ultrasound image-guided targeting approach. Ageeli W; Wei C; Zhang X; Szewcyk-Bieda M; Wilson J; Li C; Nabi G Insights Imaging; 2021 Jul; 12(1):96. PubMed ID: 34236553 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy. Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747 [TBL] [Abstract][Full Text] [Related]